Comparative Evaluation of Fluid Absorbency of Retraction Cord after Immersing in Two Alpha Adrenomimetic Medicaments—An In Vitro Study Authors: Balamurugan Gurunathan, Tripty Rahangdale, Manisha Parpiyani, Reny K. Ninan, Arsh Dhamane, Shivangi Raghav Published: 2024 ABSTRACT ABSTRACTAim:The aim was to compare and evaluate the fluid absorbency of retraction cord after immersing in ZOAMETTM nasal decongestant and VIZOLINETM eye decongestant.Material and Method:A total of 90 pieces, each 50 mm long, were divided into three groups of 30. Group 1 consisted of untreated cords, while Groups 2 and 3 involved cords immersed in both solutions for 20 minutes, respectively. Further subgroups were divided based on immersion in artificial saliva and plasma. When immersed in medicaments, a significant difference in the absorption of fluids (artificial saliva and plasma) and between the two solutions was observed.Result and Conclusion:It was concluded that both the agents are safe to be used for gingival retraction; among the two, VIZOLINETM gave more efficient results. INTRODUCTION Accurate impression recording is essential for successful prosthesis fabrication, and maintaining a dry field is crucial for this process.[1] Various “Gingival Retraction Methods” are employed to achieve this, improving visibility and facilitating access to a clean, dry gingival sulcus. This is particularly beneficial for both direct and indirect tooth restorations, especially when dealing with subgingival finish lines. The debate over fluid absorbency has persisted for decades, playing a crucial role in the accuracy of impression recording and directly impacting the marginal fit of the resulting prosthesis.[2] Even when using impression materials with optimal properties, the fit of the prosthesis can be compromised if the margin is not properly displaced or if there is contamination from saliva or blood. To address these issues, various retraction methods have been developed over time.[3] These techniques not only help displace the gingival tissue, allowing for an adequate bulk of impression material in the gingival sulcus, but also minimize the risk of moisture contamination. A minimum gap of 0.15 to 0.20 mm is recommended to ensure an adequate bulk of impression material around the margins of the preparation. Gingival retraction methods can be categorized into three types: (1) mechanical, (2) mechanochemical, and (3) surgical.[4] The surgical method causes irreversible soft tissue damage and can trigger inflammation in surrounding areas, making it infrequently used. Mechanical methods rely on the physical displacement of the gingiva using plain retraction cords, used for patients with minimal fluid seepage or bleeding.[5] The mechanochemical retraction method is the most commonly utilized technique. Medicated retraction cords should achieve adequate lateral and vertical displacement of gingival tissues while promoting tissue shrinkage and controlling hemorrhage and fluids, ensuring a proper impression of the prepared tooth’s gingival finish line.[6] Various medicaments used for gingival retraction include epinephrine, aluminum chloride, aluminum sulfate, alum, ferric sulfate, and subsulfate.[7] The drawbacks of conventional retraction agents have prompted ongoing scientific research to find more biologically compatible compounds for cord impregnation. Bowel et al.[8] highlighted a new application for nasal and eye decongestants, including oxymetazoline hydrochloride 0.05% (AFRINTM), tetrahydrozoline hydrochloride 0.05% (VISINETM), and phenylephrine hydrochloride 0.25% (NEOSYNEPHRINETM). MATERIAL AND METHOD This study was conducted in the Department of Prosthodontics and Crown and Bridge at Mansarovar Dental College, Bhopal, focusing on Ultrapak™ knitted retraction cord #1. A total of 90 pieces, each 50 mm long, were divided into three groups of 30. Group 1 consisted of untreated cords, while Groups 2 and 3 involved cords immersed in VIZOLINE™ (tetrahydrozoline hydrochloride 0.05%) and ZOAMET™ (oxymetazoline hydrochloride 0.05%) solutions for 20 minutes, respectively. Each group was further split into subgroups based on immersion in either human plasma or artificial saliva for 10 minutes [Figure 1]. Initial weights of the dry and treated cords were recorded using an electronic analytical balance, and excess fluid was removed with blotting paper after immersions. The process ensured consistent lengths and thicknesses across all samples, allowing for a thorough evaluation of fluid absorbency in different conditions. The collected data were statistically analyzed using one-way ANOVA and Tukey’s post hoc test. Grouping of samples RESULTS The study results indicated that Ultrapak™ retraction cords immersed in artificial saliva exhibited greater fluid absorbency (64.00 mg) compared to those immersed in human plasma (62.20 mg). Additionally, cords treated with VIZOLINE™ 0.05% solution, followed by artificial saliva, demonstrated higher absorbency (65.07 mg) than those treated with ZOAMET™ 0.05% solution and then artificial saliva (59.93 mg). Similarly, cords immersed in VIZOLINE™ 0.05% solution and then human plasma (63.47 mg) had more absorbency than those treated with ZOAMET™ 0.05% solution and then human plasma (59.93 mg). Furthermore, the absorbency of cords treated with VIZOLINE™ 0.05% solution and subsequently immersed in either artificial saliva (65.07 mg) or human plasma (63.47 mg) was greater than those immersed directly in artificial saliva (59.93 mg) and human plasma (59.93 mg). Interestingly, cords treated with VIZOLINE™ 0.05% solution and then human plasma (63.47 mg) showed less absorbency than those immersed in artificial saliva (64.00 mg). Lastly, cords immersed in artificial saliva (64.00 mg) and human plasma (62.20 mg) had higher absorbency than those treated with ZOAMET™ 0.05% solution, followed by artificial saliva (59.93 mg) and human plasma (59.93 mg) [Graph 1]. Mean fluid absorbency DISCUSSION The present study aimed to evaluate the fluid absorbency of Ultrapak™ retraction cords after immersion in ZOAMET™ 0.05% nasal decongestant and VIZOLINE™ 0.05% eye decongestant. Ultrapak™ retraction cords were selected for their unique knitted weave, which minimizes unraveling during cutting and placement. These cords feature interlocking loops capable of holding approximately 2.5 times more hemostatic solution than conventional options. Using thickness #1, all samples measured 50 mm in length, consistent with research by Vishnubhatla et al.[1] This study used 30 retraction cords of thicknesses 0, 1, and 2, also measuring 50 mm, to assess fluid absorbency after soaking in aluminum chloride and ferric sulfate. The immersion fluids were chosen to replicate conditions in the gingival sulcus, where blood and saliva may be present during retraction procedures, necessitating effective clearance for optimal impressions. The results indicated that retraction cords treated with VIZOLINE™ (0.05% tetrahydrozoline HCl) demonstrated greater fluid absorbency compared to those treated with ZOAMET™ (0.05% oxymetazoline HCl), as well as untreated cords. This suggests that soaking the cords in a hemostatic solution enhances their ability to absorb fluid from the gingival sulcus. Previous studies, such as those by Bowles et al.,[9] confirmed the strong local vasoconstrictive effects of tetrahydrozoline without systemic reactions, while Tardy et al.[10] highlighted its superior retraction efficiency compared to epinephrine. Kumbuloglu et al.[11] noted that effective hemostatic action depends on the amount of medicament absorbed, which is influenced by the cord’s length, thickness, structure, and soaking duration. However, our findings, in contrast with Katreva et al.[12] in his study, reported that xylometazoline 0.05% was an excellent impregnating agent for chemo-mechanical retraction of the free gingival margin. CONCLUSION It was concluded that both the agents are safe to be used for gingival retraction; among the two, VIZOLINETM gave more efficient results. Also, all retraction cords had better efficiency for saliva than plasma, as observed by one-way ANOVA. The limitations included that it was an in vitro study and therefore could not exactly simulate the oral cavity. Also, plasma differs from GCF and artificial saliva is not exactly similar to human saliva. Conflicts of interest There are no conflicts of interest.